Loading…
Role of tumor necrosis factor-[alpha], interleukin-1[beta], interleukin-6 in liver inflammation in chronic hepatitis B and chronic hepatitis C
Aims: Cytokines play important roles in the immunopathogenesis of chronic hepatitis B (CHB) and chronic hepatitis C (CHC) infections. The aim of this study was to examine the changes in serum levels of interleukin (IL)-1[beta], IL-6 and tumor necrosis factor (TNF)-[alpha] cytokines in patients with...
Saved in:
Published in: | Gülhane tıp dergisi 2021-09, Vol.63 (3) |
---|---|
Main Authors: | , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | |
---|---|
cites | |
container_end_page | |
container_issue | 3 |
container_start_page | |
container_title | Gülhane tıp dergisi |
container_volume | 63 |
creator | Senol, Arzu Alayunt, Naci Omer Solmaz, Ozgen Arslan |
description | Aims: Cytokines play important roles in the immunopathogenesis of chronic hepatitis B (CHB) and chronic hepatitis C (CHC) infections. The aim of this study was to examine the changes in serum levels of interleukin (IL)-1[beta], IL-6 and tumor necrosis factor (TNF)-[alpha] cytokines in patients with CHB and CHC, and the relationship of these cytokines with chronic inflammation, disease progression and fibrosis. Methods: We prospectively enrolled patients with CHB and CHC and control subjects from August 2016 to August 2018. Liver biopsy samples were obtained as a part of the routine care. Serum levels of IL-6, IL-1[beta], and TNF-[alpha] were determined by the enzyme-linked immunosorbent assay method. Results: The final sample included 90 patients with CHB (age, mean[+ or -]SD: 42.6[+ or -]11.8) 40 patients with CHC (age, mean[+ or -]SD: 45.1[+ or -]13.6) and 50 controls (age, mean[+ or -]SD: 39[+ or -]15.0). IL- 1[beta], TNF-[alpha] and IL-6 serum levels were statistically significantly higher in patients with CHB and CHC than in the control group [IL-1[beta] (ng/mL): 133.7[+ or -]37.0, 125.92[+ or -]12.7, 85.7[+ or -]9.8; TNF-[alpha] (ng/mL): 307.9[+ or -]68.9, 286.0[+ or -]43.2, 72.0[+ or -]14.01; IL-6 (ng/mL): 50.6[+ or -]10.1, 55.07[+ or -]9.79, 8.85[+ or -]7.07, respectively, p=0.001]. TNF-[alpha] level was statistically significantly higher in patients with significant fibrosis (320.5[+ or -]36.9) than those with mild fibrosis (257.3[+ or -]21.6) (p=0.04). Alpha-fetoprotein level was statistically significantly higher in CHC patients than CHB and control groups. Conclusions: This study showed increased levels of IL-1[beta], IL-6 and TNF-[alpha] in CHB and CHC patients. TNF-[alpha] level further increased in patients with documented liver fibrosis. Keywords: Chronic hepatitis B, chronic hepatitis C, IL-1[beta], IL-6, TNF-[alpha] |
doi_str_mv | 10.4274/gulhane.galenos.2021.1338 |
format | article |
fullrecord | <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A679086021</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A679086021</galeid><sourcerecordid>A679086021</sourcerecordid><originalsourceid>FETCH-LOGICAL-g671-166e3541d118d49cc2830ef2a443b58d21380dcc82af8265d769256503585ba73</originalsourceid><addsrcrecordid>eNptkN1KAzEQhXOhYK2-Q8Rbd83PJpte1uIfFATpXZGSTSbdaDYpu1sfw2c2RS9EylzMzMeZw3AQuqKkrFhd3W73odURyq0OENNQMsJoSTlXJ2hCOWEFqWp6hs6H4Z0QKQVVE_T1mgLg5PC471KPI5g-DX7ATpsx9cVah12r326wjyP0AfYfPhZ03cD4H8q84eA_oc-DC7rr9OhTPFDT9il6g1vYZTZm9zusoz3CFxfo1OkwwOVvn6LVw_1q8VQsXx6fF_NlsZU1LaiUwEVFLaXKVjNjmOIEHNNVxRuhLKNcEWuMYtopJoWt5YwJKQgXSjS65lN0_WN7iGqT_01jr03nB7OZy3pGlMzRZVV5RJXLQudNiuB85n8OvgFXWnhf</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Role of tumor necrosis factor-[alpha], interleukin-1[beta], interleukin-6 in liver inflammation in chronic hepatitis B and chronic hepatitis C</title><source>Publicly Available Content (ProQuest)</source><creator>Senol, Arzu ; Alayunt, Naci Omer ; Solmaz, Ozgen Arslan</creator><creatorcontrib>Senol, Arzu ; Alayunt, Naci Omer ; Solmaz, Ozgen Arslan</creatorcontrib><description>Aims: Cytokines play important roles in the immunopathogenesis of chronic hepatitis B (CHB) and chronic hepatitis C (CHC) infections. The aim of this study was to examine the changes in serum levels of interleukin (IL)-1[beta], IL-6 and tumor necrosis factor (TNF)-[alpha] cytokines in patients with CHB and CHC, and the relationship of these cytokines with chronic inflammation, disease progression and fibrosis. Methods: We prospectively enrolled patients with CHB and CHC and control subjects from August 2016 to August 2018. Liver biopsy samples were obtained as a part of the routine care. Serum levels of IL-6, IL-1[beta], and TNF-[alpha] were determined by the enzyme-linked immunosorbent assay method. Results: The final sample included 90 patients with CHB (age, mean[+ or -]SD: 42.6[+ or -]11.8) 40 patients with CHC (age, mean[+ or -]SD: 45.1[+ or -]13.6) and 50 controls (age, mean[+ or -]SD: 39[+ or -]15.0). IL- 1[beta], TNF-[alpha] and IL-6 serum levels were statistically significantly higher in patients with CHB and CHC than in the control group [IL-1[beta] (ng/mL): 133.7[+ or -]37.0, 125.92[+ or -]12.7, 85.7[+ or -]9.8; TNF-[alpha] (ng/mL): 307.9[+ or -]68.9, 286.0[+ or -]43.2, 72.0[+ or -]14.01; IL-6 (ng/mL): 50.6[+ or -]10.1, 55.07[+ or -]9.79, 8.85[+ or -]7.07, respectively, p=0.001]. TNF-[alpha] level was statistically significantly higher in patients with significant fibrosis (320.5[+ or -]36.9) than those with mild fibrosis (257.3[+ or -]21.6) (p=0.04). Alpha-fetoprotein level was statistically significantly higher in CHC patients than CHB and control groups. Conclusions: This study showed increased levels of IL-1[beta], IL-6 and TNF-[alpha] in CHB and CHC patients. TNF-[alpha] level further increased in patients with documented liver fibrosis. Keywords: Chronic hepatitis B, chronic hepatitis C, IL-1[beta], IL-6, TNF-[alpha]</description><identifier>ISSN: 1302-0471</identifier><identifier>DOI: 10.4274/gulhane.galenos.2021.1338</identifier><language>eng</language><publisher>Galenos Yayinevi Tic. Ltd</publisher><subject>Development and progression ; Diseases ; Enzyme-linked immunosorbent assay ; Enzymes ; Health aspects ; Hepatitis B ; Hepatitis C ; Interleukins ; Liver ; Medical research ; Medicine, Experimental ; Necrosis ; Tumor necrosis factor</subject><ispartof>Gülhane tıp dergisi, 2021-09, Vol.63 (3)</ispartof><rights>COPYRIGHT 2021 Galenos Yayinevi Tic. Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids></links><search><creatorcontrib>Senol, Arzu</creatorcontrib><creatorcontrib>Alayunt, Naci Omer</creatorcontrib><creatorcontrib>Solmaz, Ozgen Arslan</creatorcontrib><title>Role of tumor necrosis factor-[alpha], interleukin-1[beta], interleukin-6 in liver inflammation in chronic hepatitis B and chronic hepatitis C</title><title>Gülhane tıp dergisi</title><description>Aims: Cytokines play important roles in the immunopathogenesis of chronic hepatitis B (CHB) and chronic hepatitis C (CHC) infections. The aim of this study was to examine the changes in serum levels of interleukin (IL)-1[beta], IL-6 and tumor necrosis factor (TNF)-[alpha] cytokines in patients with CHB and CHC, and the relationship of these cytokines with chronic inflammation, disease progression and fibrosis. Methods: We prospectively enrolled patients with CHB and CHC and control subjects from August 2016 to August 2018. Liver biopsy samples were obtained as a part of the routine care. Serum levels of IL-6, IL-1[beta], and TNF-[alpha] were determined by the enzyme-linked immunosorbent assay method. Results: The final sample included 90 patients with CHB (age, mean[+ or -]SD: 42.6[+ or -]11.8) 40 patients with CHC (age, mean[+ or -]SD: 45.1[+ or -]13.6) and 50 controls (age, mean[+ or -]SD: 39[+ or -]15.0). IL- 1[beta], TNF-[alpha] and IL-6 serum levels were statistically significantly higher in patients with CHB and CHC than in the control group [IL-1[beta] (ng/mL): 133.7[+ or -]37.0, 125.92[+ or -]12.7, 85.7[+ or -]9.8; TNF-[alpha] (ng/mL): 307.9[+ or -]68.9, 286.0[+ or -]43.2, 72.0[+ or -]14.01; IL-6 (ng/mL): 50.6[+ or -]10.1, 55.07[+ or -]9.79, 8.85[+ or -]7.07, respectively, p=0.001]. TNF-[alpha] level was statistically significantly higher in patients with significant fibrosis (320.5[+ or -]36.9) than those with mild fibrosis (257.3[+ or -]21.6) (p=0.04). Alpha-fetoprotein level was statistically significantly higher in CHC patients than CHB and control groups. Conclusions: This study showed increased levels of IL-1[beta], IL-6 and TNF-[alpha] in CHB and CHC patients. TNF-[alpha] level further increased in patients with documented liver fibrosis. Keywords: Chronic hepatitis B, chronic hepatitis C, IL-1[beta], IL-6, TNF-[alpha]</description><subject>Development and progression</subject><subject>Diseases</subject><subject>Enzyme-linked immunosorbent assay</subject><subject>Enzymes</subject><subject>Health aspects</subject><subject>Hepatitis B</subject><subject>Hepatitis C</subject><subject>Interleukins</subject><subject>Liver</subject><subject>Medical research</subject><subject>Medicine, Experimental</subject><subject>Necrosis</subject><subject>Tumor necrosis factor</subject><issn>1302-0471</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptkN1KAzEQhXOhYK2-Q8Rbd83PJpte1uIfFATpXZGSTSbdaDYpu1sfw2c2RS9EylzMzMeZw3AQuqKkrFhd3W73odURyq0OENNQMsJoSTlXJ2hCOWEFqWp6hs6H4Z0QKQVVE_T1mgLg5PC471KPI5g-DX7ATpsx9cVah12r326wjyP0AfYfPhZ03cD4H8q84eA_oc-DC7rr9OhTPFDT9il6g1vYZTZm9zusoz3CFxfo1OkwwOVvn6LVw_1q8VQsXx6fF_NlsZU1LaiUwEVFLaXKVjNjmOIEHNNVxRuhLKNcEWuMYtopJoWt5YwJKQgXSjS65lN0_WN7iGqT_01jr03nB7OZy3pGlMzRZVV5RJXLQudNiuB85n8OvgFXWnhf</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Senol, Arzu</creator><creator>Alayunt, Naci Omer</creator><creator>Solmaz, Ozgen Arslan</creator><general>Galenos Yayinevi Tic. Ltd</general><scope/></search><sort><creationdate>20210901</creationdate><title>Role of tumor necrosis factor-[alpha], interleukin-1[beta], interleukin-6 in liver inflammation in chronic hepatitis B and chronic hepatitis C</title><author>Senol, Arzu ; Alayunt, Naci Omer ; Solmaz, Ozgen Arslan</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g671-166e3541d118d49cc2830ef2a443b58d21380dcc82af8265d769256503585ba73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Development and progression</topic><topic>Diseases</topic><topic>Enzyme-linked immunosorbent assay</topic><topic>Enzymes</topic><topic>Health aspects</topic><topic>Hepatitis B</topic><topic>Hepatitis C</topic><topic>Interleukins</topic><topic>Liver</topic><topic>Medical research</topic><topic>Medicine, Experimental</topic><topic>Necrosis</topic><topic>Tumor necrosis factor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Senol, Arzu</creatorcontrib><creatorcontrib>Alayunt, Naci Omer</creatorcontrib><creatorcontrib>Solmaz, Ozgen Arslan</creatorcontrib><jtitle>Gülhane tıp dergisi</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Senol, Arzu</au><au>Alayunt, Naci Omer</au><au>Solmaz, Ozgen Arslan</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of tumor necrosis factor-[alpha], interleukin-1[beta], interleukin-6 in liver inflammation in chronic hepatitis B and chronic hepatitis C</atitle><jtitle>Gülhane tıp dergisi</jtitle><date>2021-09-01</date><risdate>2021</risdate><volume>63</volume><issue>3</issue><issn>1302-0471</issn><abstract>Aims: Cytokines play important roles in the immunopathogenesis of chronic hepatitis B (CHB) and chronic hepatitis C (CHC) infections. The aim of this study was to examine the changes in serum levels of interleukin (IL)-1[beta], IL-6 and tumor necrosis factor (TNF)-[alpha] cytokines in patients with CHB and CHC, and the relationship of these cytokines with chronic inflammation, disease progression and fibrosis. Methods: We prospectively enrolled patients with CHB and CHC and control subjects from August 2016 to August 2018. Liver biopsy samples were obtained as a part of the routine care. Serum levels of IL-6, IL-1[beta], and TNF-[alpha] were determined by the enzyme-linked immunosorbent assay method. Results: The final sample included 90 patients with CHB (age, mean[+ or -]SD: 42.6[+ or -]11.8) 40 patients with CHC (age, mean[+ or -]SD: 45.1[+ or -]13.6) and 50 controls (age, mean[+ or -]SD: 39[+ or -]15.0). IL- 1[beta], TNF-[alpha] and IL-6 serum levels were statistically significantly higher in patients with CHB and CHC than in the control group [IL-1[beta] (ng/mL): 133.7[+ or -]37.0, 125.92[+ or -]12.7, 85.7[+ or -]9.8; TNF-[alpha] (ng/mL): 307.9[+ or -]68.9, 286.0[+ or -]43.2, 72.0[+ or -]14.01; IL-6 (ng/mL): 50.6[+ or -]10.1, 55.07[+ or -]9.79, 8.85[+ or -]7.07, respectively, p=0.001]. TNF-[alpha] level was statistically significantly higher in patients with significant fibrosis (320.5[+ or -]36.9) than those with mild fibrosis (257.3[+ or -]21.6) (p=0.04). Alpha-fetoprotein level was statistically significantly higher in CHC patients than CHB and control groups. Conclusions: This study showed increased levels of IL-1[beta], IL-6 and TNF-[alpha] in CHB and CHC patients. TNF-[alpha] level further increased in patients with documented liver fibrosis. Keywords: Chronic hepatitis B, chronic hepatitis C, IL-1[beta], IL-6, TNF-[alpha]</abstract><pub>Galenos Yayinevi Tic. Ltd</pub><doi>10.4274/gulhane.galenos.2021.1338</doi></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1302-0471 |
ispartof | Gülhane tıp dergisi, 2021-09, Vol.63 (3) |
issn | 1302-0471 |
language | eng |
recordid | cdi_gale_infotracmisc_A679086021 |
source | Publicly Available Content (ProQuest) |
subjects | Development and progression Diseases Enzyme-linked immunosorbent assay Enzymes Health aspects Hepatitis B Hepatitis C Interleukins Liver Medical research Medicine, Experimental Necrosis Tumor necrosis factor |
title | Role of tumor necrosis factor-[alpha], interleukin-1[beta], interleukin-6 in liver inflammation in chronic hepatitis B and chronic hepatitis C |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-05T12%3A44%3A21IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20tumor%20necrosis%20factor-%5Balpha%5D,%20interleukin-1%5Bbeta%5D,%20interleukin-6%20in%20liver%20inflammation%20in%20chronic%20hepatitis%20B%20and%20chronic%20hepatitis%20C&rft.jtitle=Gu%CC%88lhane%20t%C4%B1p%20dergisi&rft.au=Senol,%20Arzu&rft.date=2021-09-01&rft.volume=63&rft.issue=3&rft.issn=1302-0471&rft_id=info:doi/10.4274/gulhane.galenos.2021.1338&rft_dat=%3Cgale%3EA679086021%3C/gale%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-g671-166e3541d118d49cc2830ef2a443b58d21380dcc82af8265d769256503585ba73%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A679086021&rfr_iscdi=true |